-
Metabolic Intervention Enhances Ferroptosis and Cuproptosis
2026-06-01
This study presents a novel nanosystem-based metabolic intervention that synchronously sensitizes tumor cells to ferroptosis and cuproptosis by targeting glycolysis and NAD+ metabolism. The dual activation significantly boosts anti-tumor immunity, offering a promising new strategy for regulated cell death-based cancer therapies.
-
Mono-ADP-Ribosylation as a Degradation Signal in PARP7/AHR R
2026-06-01
This study demonstrates that mono-ADP-ribosylation, catalyzed by PARP7 and induced by ubiquitin pathway blockade, marks proteins such as PARP7 and the aryl hydrocarbon receptor (AHR) for degradation. The research identifies DTX2 as the responsible E3 ligase, revealing a new mechanism for rapid regulation of AHR-mediated transcription.
-
Cy5-UTP (Cyanine 5-UTP): Reliable RNA Labeling for Cell Assa
2026-05-31
This article addresses persistent challenges in RNA probe synthesis, cell viability assays, and fluorescence detection, illustrating how Cy5-UTP (Cyanine 5-UTP, SKU B8333) delivers reproducible, sensitive solutions for biomedical researchers. Drawing on literature and quantitative data, we explore real-world scenarios where Cy5-UTP's spectral clarity and workflow reliability are indispensable.
-
Cy5-UTP for In Vitro Transcription RNA Labeling: Advanced Wo
2026-05-30
Cy5-UTP (Cyanine 5-uridine triphosphate) revolutionizes RNA probe synthesis by enabling direct, high-sensitivity fluorescent labeling, ideal for FISH and dual-color expression arrays. Its optimized incorporation streamlines workflows, reduces post-transcriptional handling, and supports advanced studies of RNA trafficking and aggregation.
-
Annexin V-FITC/PI Apoptosis Kit: Advancing Translational Pre
2026-05-29
Explore how the Annexin V-FITC/PI Apoptosis Assay Kit bridges mechanistic insight and translational strategy for neurodegenerative and oncology research, expanding beyond standard protocols to address complex disease modeling and therapeutic innovation.
-
Optimizing Ceftolozane Dosing for P. aeruginosa Bacteremia
2026-05-29
The reference study provides a quantitative assessment of ceftolozane/tazobactam dosing regimens targeting bacteremia caused by Pseudomonas aeruginosa, factoring in patient renal function and minimum inhibitory concentration (MIC) distributions. These findings inform precise dosing strategies to maximize bactericidal activity, particularly in critically ill patients with variable pharmacokinetics.
-
IR-1061: Near Infrared Fluorescent Dye for Deep Tissue Imagi
2026-05-28
IR-1061, a near infrared fluorescent dye from APExBIO, enables high-sensitivity deep tissue imaging with minimized background signal. Its unique solubility and encapsulation properties streamline the preparation of robust in vivo imaging probes, outperforming traditional inorganic agents in both ease of use and biocompatibility.
-
Peripheral Endosome Entrapment Limits LNP Trafficking and Es
2026-05-28
This study reveals that lipid nanoparticles (LNPs) trapped in peripheral endosomes—but not lysosomes—face impaired trafficking and reduced cytosolic release, undermining delivery efficiency. The findings provide new insights into intracellular barriers for nucleic acid therapeutics and highlight the need for advanced spatiotemporal analysis and labeling strategies.
-
Cy5-UTP (Cyanine 5-UTP): Precision RNA Labeling for FISH and
2026-05-27
Cy5-UTP (Cyanine 5-UTP) enables direct, high-sensitivity RNA labeling via in vitro transcription. Its robust fluorescence streamlines probe synthesis for FISH and dual-color expression arrays. The reagent's physicochemical stability and compatibility with standard T7 RNA polymerase protocols make it a benchmark choice for molecular biology applications.
-
Ferritin-Based Hybrid Protein Particle Vaccine for Influenza
2026-05-27
This study introduces a novel ferritin-based hybrid protein particle vaccine that combines the M2e antigen of influenza A virus with S-protein tandem epitopes from SARS-CoV-2, co-assembled in E. coli. The platform enhances immunogenicity and provides a versatile foundation for combination vaccine development, with implications for robust, multivalent immune responses.
-
(S)-(+)-Dimethindene maleate for M2 Antagonist Studies: Prot
2026-05-26
(S)-(+)-Dimethindene maleate enables selective antagonism of muscarinic M2 and histamine H1 receptors, supporting precise receptor profiling in autonomic regulation and cardiovascular physiology research. It is best applied where high receptor selectivity and rapid solution preparation are prioritized, but should not be used for long-term solution storage or any application outside controlled laboratory research.
-
ROS-Responsive Nanoplatform for Mitochondrial Repair in Diab
2026-05-26
This study introduces a hierarchically targeted, ROS-responsive nanoparticle-hydrogel system for treating diabetic periodontitis by repairing mitochondrial dysfunction in M1 macrophages. The research demonstrates that local delivery of this platform decreases inflammation and supports bone regeneration, providing a new therapeutic framework for chronic inflammatory oral disease.
-
BCECF-AM: Precision Intracellular pH Sensing in Plant Cell S
2026-05-25
Explore how BCECF-AM enables highly accurate intracellular pH measurement in the context of plant protein secretion studies. This article offers a mechanistic deep dive and protocol guidance, revealing unique insights not covered in prior reviews.
-
Ether Lipid Biosynthesis in B Cells Regulates Germinal Cente
2026-05-25
The referenced study reveals that B cell–intrinsic expression of the ether lipid biosynthetic enzyme PexRAP is essential for robust antibody responses and proper germinal center formation. Using inducible genetic models, the authors delineate a direct metabolic mechanism linking ether phospholipid synthesis to B cell survival, proliferation, and humoral immunity, providing a new perspective for immunometabolism research.
-
AIBP-LRP2–HDL Axis Restricts CXCR4+ Capillary Expansion in I
2026-05-24
Zhu et al. uncover a two-phase mechanism by which AIBP-LRP2–mediated HDL uptake in endothelial cells limits the expansion of CXCR4+ stemlike capillaries, thereby restricting collateral vessel formation in ischemic muscle. These findings clarify how lipid metabolism intersects with vascular remodeling and highlight new molecular targets for therapeutic revascularization.